Bioequivalence Study of Glimepiride 1mg Tablets Under Fasting Conditions

The study was conducted as an open label, balanced, randomised, two-treatment, two-period, two-sequence, single-dose, crossover , bioequivalence study on glimepiride comparing glimepiride 1mg tablets of Ranbaxy laboratories limited with Amaryl 1mg tablets of in healthy, adult, human, subjects under fasting conditions. A total of 32 subjects were entered into this study and 31 subjects completed the study.